Related Experiment Videos

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

L del Peso1, M González-García, C Page

  • 1Department of Pathology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Science (New York, N.Y.)
|October 24, 1997
PubMed

Insights

Interleukin-3 (IL-3) signaling activates the phosphoinositide 3-kinase (PI 3-kinase)-Akt pathway, which phosphorylates BAD and inhibits its cell death-promoting function. This pathway thus regulates BAD

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • BAD is a pro-apoptotic protein belonging to the Bcl-2 family.
  • Phosphorylation of BAD inhibits its pro-apoptotic activity.
  • Interleukin-3 (IL-3) is known to promote cell survival.

Purpose of the Study:

  • To investigate the mechanism by which IL-3 inhibits BAD-mediated apoptosis.
  • To identify the signaling pathway responsible for BAD phosphorylation induced by IL-3.

Main Methods:

  • Utilized specific inhibitors of phosphoinositide 3-kinase (PI 3-kinase).
  • Assessed the activation of Akt, a serine-threonine protein kinase.
  • Performed in vivo and in vitro phosphorylation assays of BAD by Akt.

Main Results:

  • IL-3-induced BAD phosphorylation was blocked by PI 3-kinase inhibitors.
  • IL-3 activated Akt in a PI 3-kinase-dependent manner.
  • Active Akt phosphorylated BAD at the same residues as IL-3 treatment.

Conclusions:

  • The PI 3-kinase-Akt pathway is crucial for IL-3-mediated inhibition of BAD.
  • Akt directly phosphorylates BAD, thereby regulating its pro-apoptotic function.
  • This signaling cascade represents a key mechanism for cell survival signaling.

Related Concept Videos